Victoria Palatnik

At tyred, were revolutionising micro-mobility with a service philosophy anchored in three foundational pillars: Simplicity, Convenience, and Scalability. Our mission is to ensure seamless on-site mobile repairs for every traveller, regardless of their mode of micro-mobility. Whether you manage a fleet of cargo bikes for your business, enjoy cycling through the city, rely on a wheelchair for mobility, or are a corporate entity aiming to promote sustainable commuting among your employees, tyred is your ever-ready ally. Our vision is to create a world where sustainable travel is not just a choice but a convenient lifestyle. With tyred, help is just a call away, ensuring that your journey continues smoothly, no matter where you are or what challenges you face. Join us in making sustainable micro-mobility the cornerstone of daily travel. Welcome to tyred - where innovation, inclusivity, and sustainability propel us forward.

Signapse is a Sign Language translation software company that uses Generative AI to achieve photo-realism and accuracy to provide greater accessibility for the Deaf community. Broadcast media, announcements in public spaces, and websites can be inaccessible if you are a sign language user and it is our job to make sure your organisation provides great access for Deaf people. All of the world’s digital information currently exists in a written and audible format. Signapse won’t stop until all this information is automatically available in Sign Language.

At Fraiya Ltd, our mission is to revolutionize the field of ultrasound through cutting-edge artificial intelligence technology. Fraiya aims to elevate the standard of prenatal care by advancing the accuracy, consistency, and efficiency of ultrasound, supporting more confident clinical decisions and a more reassuring experience for every mother and baby. The Fraiya Platform is designed to work together across the prenatal pathway, starting with the anomaly scan, to improve consistency, reduce workload and raise the standard of care.

iFAST is developing a game-changing, rapid antimicrobial susceptibility test, that will enable every patient with bacterial infections to receive the right antibiotic, on time, every time. Currently, these tests take 48-72 hours, but iFASTs tests are 10x faster - giving full quantitative and qualitative results in under 3 hours from a positive blood culture or bacterial isolate. The technology is cheaper and involve less tedious manual labour than current standard of care, which is based on technology from the mid-1900s! We also offer high throughout (most labs only need one system to accommodate all their requirements). This is a $4bn market and we will be launching on the UK market at the start of 2026, and in the US and EU the following year.

Inflammatix is advancing emergency and critical care medicine by leveraging the body’s immune response to support timely, informed decision-making for patients with suspected acute infection or sepsis. TriVerity™ is an FDA-cleared, rapid blood test that applies AI-driven analysis of immune mRNA expression to deliver three results in approximately 30 minutes: likelihood of bacterial infection, likelihood of viral infection, and risk of near-term clinical deterioration. By reducing diagnostic uncertainty early in the patient encounter, TriVerity supports risk stratification and clinical assessment in the emergency department, helping clinicians better understand which patients may require closer monitoring or inpatient care and which patients may be appropriate for lower-acuity pathways. Inflammatix translates immune response data into real-time clinical insights designed to support high-quality care delivery while aligning with health system priorities around operational efficiency, antimicrobial stewardship, and value-based performance.

Welcome to EZbra: Redefining Recovery with Innovation and Care At EZbra, we are pioneering advancements in wound care, standing at the forefront of medical device innovation. Our flagship product, EZbra, is the world’s first and only sterile, disposable, and adjustable breast dressing, tailored to meet the unique needs of patients and healthcare professionals alike. Each year, over 17 million breast procedures are performed, and EZbra is designed to cater to the diverse requirements that arise during recovery. Our all-in-one, absorptive dressing not only provides essential support but also empowers patients with independence and confidence during their healing journey. With a controlled compression system and an elegant design, EZbra transforms the recovery experience, allowing patients to manage their dressing changes with grace. For surgeons and nurses, EZbra offers a personalized, easy-to-apply solution that streamlines the post-operative process. Our device adapts to each patients specific needs, ensuring both safety and comfort while enhancing efficiency in the operating room. Fuelled by our proprietary organ-designated dressings, we are committed to developing a comprehensive pipeline of innovative treatments that address the anatomical, medical, and emotional needs of patients. At EZbra, we aim to reshape the wound care landscape, moving beyond stagnation and fostering a new era of recovery, dignity, and empowerment. Join us on this transformative journey as we advance the future of wound care—one dressing at a time. EZbra-Recover With Dignity

Jay is the leading provider of shoppable content and in-stream bonus feature technology to streaming services. Unlocking viewer engagement and revenue development opportunities, Jay is changing the way audiences engage with their favourite shows. By seamlessly integrating commerce, content and information into shows on a scene-by-scene basis, viewers gain instant access to content about the cast, music, costumes or products featured. Similar products can be bought directly without leaving the media player. Jay was founded by Peter Effenberg in 2022 after ten years in development.

Founded in 2020, Balena is a material science company, developing advanced, compostable, recyclable, and bio-based thermoplastic materials. Balena is on a mission to create a circular model for durable consumer goods products and solve one of the industrys biggest challenges: the products end-of-life, while reducing the dependency on fossil fuels.

Fermata builds AI-powered decision support systems for precise plant monitoring in greenhouses & indoor farms utilizing computer vision analysis. Our Croptimus platform automatically discovers pests and disease at their earliest stages, helping our customers to spend less time scouting while increasing their yield.

VYRTY™ Corporation, doing business as Sync.MD®, was founded in 2015 in Redmond, WA, to provide patients with superior mobile technology to collect, store, and share their personal health information. Started through a unique partnership between technology leaders and dedicated healthcare providers, Sync.MD® set out to ease the communication burden between disparate electronic medical record systems through patented, innovative technologies that place the patient at the center of their information exchange. Sync.MD® is a developer of a patented, MultiDimensional technology which allows users to become the true custodian of their health records through a patient-centric digital platform that places the power of information exchange at their fingertips. We entered the marketplace with our mobile personal health record (PHR) application in 2017. The Sync.MD app enables individuals to collect and securely store their complete and current health records, and upload documents on their smartphone for seamless sharing of medical records with healthcare providers. Today, the company has relocated to Anderson, SC, and expanded their technological capabilities by adding identity verification, e-signatures, e-forms, and B2C and B2B secure document storage and exchange. No longer just in the healthcare industry, Sync.MD® has entered the automotive, financial services, real estate, and government industries with our patented secure data exchange technology solutions.

We built a human being. In digital form. Created by medical professionals with a passion for technology and technology professionals with a passion for medicine, AIBODY can provide accelerated teaching of human physiology to clinical personnel, power medical technology solutions and serve pharma as a tool for streamlining R&D and clinical programs.

Founded in Israel in 2011, Beyon3D is a rapidly growing private company, scalable in products, markets, and territories. Beyon3D’s unique business model and increasing product demand, enables brand success, deep market penetration, and maximum profitability. Beyon3D is, first and foremost, a multidisciplinary building technology and industrial robotics company. Beyon3D has been the spearhead of ingenuity in the construction industry through the development of new technologies and production processes, which allow the creation of a new-age series of superior concrete building products that are unparalleled in the industry. Following years of intense R&D, Beyon3D has completed its pioneering technology and reinvented the process of design and manufacturing of innovative constructive and decorative building products, simultaneously, redefining quality and aesthetics in the field. In April 2022, Beyon3D opened its first factory in Haifa, Israel, in collaboration with Ciment (an importer of cement for the Israeli market). This factory is the first of its kind in the world to produce concrete products using unique technology developed by the company, which speeds up construction time, improves efficiency, increases productivity and local production capacity, and eliminates dependence on an international supply chain – at a low cost. The company is expanding its operations and plans to establish 25 more factories around the world. Therefore, in September 2022, Beyon3D acquired Kiddod Engineering Ltd, an Israeli engineering company that specializes in mechanical engineering, taking Beyon3D one step closer to achieving its international goals.

Direct. Easy. Secure. The worlds first trading app for buying, collecting and selling fine wine #smartwineinvestments #vindomewine

IPSY is the industry’s most powerful platform, uniting brands, creators, and hyper-engaged consumers with unprecedented access to each other. Our portfolio includes IPSY Original (our sample-size subscription), IPSY Extra (our full-size subscription), and IPSY Ultimate (our most premium full-size subscription). Powered by expert curation, product innovation, machine learning technology, and millions of member insights, we deliver highly personalized beauty experiences every month. To date, the IPSY community has generated more than 200 million product reviews, helping us make discovery smarter and more authentic. Whether you’re a beauty enthusiast or just starting your journey, IPSY is here to inspire everyone to express their unique beauty. Join us…because beauty is more fun here. Ready to join us as we empower people on their journey to self-expression and discovery? Visit our careers site to learn more about the values, culture, benefits, and more across all our brands.  https://www.ipsycorporate.com/careers

Bizzabo powers immersive in-person, virtual, and hybrid experiences. The Bizzabo Event Experience OS is a data-rich open platform that allows Event Experience Leaders to manage events, engage audiences, activate communities, and deliver powerful business outcomes — while keeping attendee data private and secure. Bizzabo powers the events of world-leading brands — from Fortune 100 enterprise organizations and financial institutions to creative agencies and scaling tech companies. Bizzabo was founded in 2011 by Boaz Katz, Alon Alroy, and Eran Ben-Shushan, and is headquartered in New York and Tel Aviv.

At tyred, were revolutionising micro-mobility with a service philosophy anchored in three foundational pillars: Simplicity, Convenience, and Scalability. Our mission is to ensure seamless on-site mobile repairs for every traveller, regardless of their mode of micro-mobility. Whether you manage a fleet of cargo bikes for your business, enjoy cycling through the city, rely on a wheelchair for mobility, or are a corporate entity aiming to promote sustainable commuting among your employees, tyred is your ever-ready ally. Our vision is to create a world where sustainable travel is not just a choice but a convenient lifestyle. With tyred, help is just a call away, ensuring that your journey continues smoothly, no matter where you are or what challenges you face. Join us in making sustainable micro-mobility the cornerstone of daily travel. Welcome to tyred - where innovation, inclusivity, and sustainability propel us forward.

Signapse is a Sign Language translation software company that uses Generative AI to achieve photo-realism and accuracy to provide greater accessibility for the Deaf community. Broadcast media, announcements in public spaces, and websites can be inaccessible if you are a sign language user and it is our job to make sure your organisation provides great access for Deaf people. All of the world’s digital information currently exists in a written and audible format. Signapse won’t stop until all this information is automatically available in Sign Language.

At Fraiya Ltd, our mission is to revolutionize the field of ultrasound through cutting-edge artificial intelligence technology. Fraiya aims to elevate the standard of prenatal care by advancing the accuracy, consistency, and efficiency of ultrasound, supporting more confident clinical decisions and a more reassuring experience for every mother and baby. The Fraiya Platform is designed to work together across the prenatal pathway, starting with the anomaly scan, to improve consistency, reduce workload and raise the standard of care.

iFAST is developing a game-changing, rapid antimicrobial susceptibility test, that will enable every patient with bacterial infections to receive the right antibiotic, on time, every time. Currently, these tests take 48-72 hours, but iFASTs tests are 10x faster - giving full quantitative and qualitative results in under 3 hours from a positive blood culture or bacterial isolate. The technology is cheaper and involve less tedious manual labour than current standard of care, which is based on technology from the mid-1900s! We also offer high throughout (most labs only need one system to accommodate all their requirements). This is a $4bn market and we will be launching on the UK market at the start of 2026, and in the US and EU the following year.

Inflammatix is advancing emergency and critical care medicine by leveraging the body’s immune response to support timely, informed decision-making for patients with suspected acute infection or sepsis. TriVerity™ is an FDA-cleared, rapid blood test that applies AI-driven analysis of immune mRNA expression to deliver three results in approximately 30 minutes: likelihood of bacterial infection, likelihood of viral infection, and risk of near-term clinical deterioration. By reducing diagnostic uncertainty early in the patient encounter, TriVerity supports risk stratification and clinical assessment in the emergency department, helping clinicians better understand which patients may require closer monitoring or inpatient care and which patients may be appropriate for lower-acuity pathways. Inflammatix translates immune response data into real-time clinical insights designed to support high-quality care delivery while aligning with health system priorities around operational efficiency, antimicrobial stewardship, and value-based performance.